You have been chosen to receive this valuable information.

A SPECIAL
ANNOUNCEMENT FROM:

Hello,

How the Life Sciences Industry cope with Big Data? Have a look at my white paper "Big Data in Pharmaceuticals: Big Opportunities or Big Challenges - or Both?", where I answer this question. Every aspect of pharmaceutical research and development involves the generation of vast quantities of data. The rapid transformation of this raw data into useful knowledge brings a lot of advantages:

•	ability to make 'data-driven' decisions
•	better understanding and control of processes
•	reduced costs and drug development time
•	facilitating rapid post-approval changes

Given this potential, the industry and regulators are eager to embed 'big data' into their decision-making process. But concerns about data integrity and parallel pressures to move to new manufacturing technologies add to the challenge of embracing 'big data.'
Read my white paper and make your own decision if Big Data in Pharmaceuticals is a big opportunity or a challenge. I hope you will find it interesting!
Kind regards, Petter Moree, OSIsoft | Life Sciences Industry Principal

© 2019 OSIsoft, LLC. • 510-297-5800 • Privacy Policy • Unsubscribe
San Leandro Tech Campus | 1600 Alvarado St. San Leandro, CA 94577

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, a UBM publication. You are on the mailing list as %%emailaddress%%.